Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan · Delayed Price · Currency is TWD 33.70
-0.35 (-1.03%)
Apr 2, 2026, 1:18 PM CST
Sofiva Genomics Market Cap
Sofiva Genomics has a market cap or net worth of 727.7 million as of April 2, 2026. Its market cap has decreased by -18.80% in one year.
Market Cap
727.70M
Enterprise Value
638.82M
Revenue
385.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.70
Market Cap Chart
Since January 5, 2017, Sofiva Genomics's market cap has decreased from 1.70B to 727.70M, a decrease of -57.17%. That is a compound annual growth rate of -8.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 727.70M | 11.77% |
| Dec 31, 2025 | 651.04M | -24.53% |
| Dec 31, 2024 | 862.66M | -1.51% |
| Dec 29, 2023 | 875.86M | 11.72% |
| Dec 30, 2022 | 784.00M | -24.75% |
| Dec 30, 2021 | 1.04B | -4.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 234.57B |
| Caliway Biopharmaceuticals | 148.78B |
| Bora Pharmaceuticals | 57.02B |
| Lotus Pharmaceutical | 56.77B |
| AmCad BioMed | 785.33M |
| Unicon Optical | 746.39M |
| BioLASCO Taiwan | 737.63M |
| SynCore Biotechnology Co.,Ltd | 719.12M |